Quantitative proton MR techniques for measuring fat

NMR in Biomedicine

Volumn 26, Issue 12, 2013, Pages 1609-1629

  Hu, H H ^a   Kan, H E ^b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Chemical shift; Ectopic fat; Fat quantification; Muscle; Obesity; Spectroscopy; Water fat MRI; White and brown adipose tissue

Indexed keywords

ADIPOSE TISSUE; ECTOPIC FAT; FAT QUANTIFICATION; FUTURE RESEARCH DIRECTIONS; MUSCULAR DYSTROPHY; OBESITY; PATHOPHYSIOLOGICAL; YIELD MEASUREMENT;

CHEMICAL SHIFT; ENZYME INHIBITION; MUSCLE; PROTONS; SPECTROSCOPY;

NUTRITION;

FAT;

ANTHROPOMETRY; BODY FAT DISTRIBUTION; BROWN ADIPOSE TISSUE; COMORBIDITY; DIET; DIFFUSION WEIGHTED IMAGING; EXERCISE; HUMAN; LIPID METABOLISM; LIPID STORAGE; MEASUREMENT ACCURACY; MUSCULAR DYSTROPHY; NUTRITION; OBESITY; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; QUANTITATIVE ANALYSIS; REVIEW; STEATOSIS;

CHEMICAL SHIFT; ECTOPIC FAT; FAT QUANTIFICATION; MUSCLE; OBESITY; SPECTROSCOPY; WATER-FAT MRI; WHITE AND BROWN ADIPOSE TISSUE;

ADIPOSE TISSUE, BROWN; ADIPOSITY; ANIMALS; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; PROTONS;

EID: 84888202975     PISSN: 09523480     EISSN: 10991492     Source Type: Journal    
DOI: 10.1002/nbm.3025     Document Type: Review

References (240)

1. Ogden CL, Carroll MD, Kit BK, Flegal KM. Prevalence of obesity and trends in body mass index among US children and adolescents, 1999-2010. J. Am. Med. Assoc. 2012; 307: 483-490.
2. McAllister EJ, Dhurandhar NV, Keith SW, Aronne LJ, Barger J, Baskin M, Benca RM, Biggio J, Boggiano MM, Eisenmann JC, Elobeid M, Fontaine KR, Gluckman P, Hanlon EC, Katzmarzyk P, Pietrobelli A, Redden DT, Ruden DM, Wang C, Waterland RA, Wright SM, Allison DB. Ten putative contributors to the obesity epidemic. Crit. Rev. Food Sci. Nutr. 2009; 49: 868-913.
3. Smith SR, Lovejoy JC, Greenway F, Ryan D, deJonge L, de la Bretonne J, Volafova J, Bray GA. Contributions of total body fat, abdominal subcutaneous adipose tissue compartments, and visceral adipose tissue to the metabolic complications of obesity. Metabolism 2001; 50: 425-435.
4. Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet 2005; 365: 1415-1428.
5. Després JP, Lemieux I, Bergeron J, Pibarot P, Mathieu P, Larose E, Rodés-Cabau J, Bertrand OF, Poirier P. Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk. Arterioscler. Thromb. Vasc. Biol. 2008; 28: 1039-1049.
6. van der Meer RW, Lamb HJ, Smit JW, de Roos A. MR imaging evaluation of cardiovascular risk in metabolic syndrome. Radiology 2012; 264: 21-37.
7. Machann J, Horstmann A, Born M, Hesse S, Hirsch FW. Diagnostic imaging in obesity. Best Pract. Res. Clin. Endocrinol. Metab. 2013; 27: 261-277.
8. Wattjes MP, Kley RA, Fischer D. Neuromuscular imaging in inherited muscle diseases. Eur. Radiol. 2010; 20: 2447-2460.
9. Reeder SB, Cruite I, Hamilton G, Sirlin CB. Quantitative assessment of liver fat with magnetic resonance imaging and spectroscopy. J. Magn. Reson. Imaging 2011; 34: 729-749.
10. Lee Y, Lingvay I, Szczepaniak LS, Ravazzola M, Orci L, Unger RH. Pancreatic steatosis: harbinger of type 2 diabetes in obese rodents. Int. J. Obes. (Lond) 2010; 34: 396-400.
11. Samara A, Ventura EE, Alfadda AA, Goran MI. Use of MRI and CT for fat imaging in children and youth: what have we learned about obesity, fat distribution and metabolic disease risk? Obes. Rev. 2012; 13: 723-732.
12. Staiano AE, Katzmarzyk PT. Ethnic and sex differences in body fat and visceral and subcutaneous adiposity in children and adolescents. Int. J. Obes. (Lond) 2012; 36: 1261-1269.
13. Hernandez TL, Kittelson JM, Law CK, Ketch LL, Stob NR, Lindstrom RC, Scherzinger A, Stamm ER, Eckel RH. Fat redistribution following suction lipectomy: defense of body fat and patterns of restoration. Obesity (Silver Spring) 2011; 19: 1388-1395.
14. van der Meer RW, Hammer S, Smit JW, Frölich M, Bax JJ, Diamant M, Rijzewijk LJ, de Roos A, Romijn JA, Lamb HJ. Short-term caloric restriction induces accumulation of myocardial triglycerides and decreases left ventricular diastolic function in healthy subjects. Diabetes 2007; 56: 2849-2853.
15. Lim EL, Hollingsworth KG, Aribisala BS, Chen MJ, Mathers JC, Taylor R. Reversal of type 2 diabetes: normalization of beta cell function in association with decreased pancreas and liver triacylglycerol. Diabetologia 2011; 54: 2506-2514.
16. Snel M, Jonker JT, Hammer S, Kerpershoek G, Lamb HJ, Meinders AE, Pijl H, de Roos A, Romijn JA, Smit JW, Jazet IM. Long-term beneficial effect of a 16-week very low calorie diet on pericardial fat in obese type 2 diabetes mellitus patients. Obesity (Silver Spring) 2012; 20: 1572-1576.
17. Lee S, Bacha F, Hannon T, Kuk JL, Boesch C, Arslanian S. Effects of aerobic versus resistance exercise without caloric restriction on abdominal fat, intrahepatic lipid, and insulin sensitivity in obese adolescent boys: a randomized, controlled trial. Diabetes 2012; 61: 2787-2795.
18. Machann J, Thamer C, Stefan N, Schwenzer NF, Kantartzis K, Häring HU, Claussen CD, Fritsche A, Schick F. Follow-up whole-body assessment of adipose tissue compartments during a lifestyle intervention in a large cohort at increased risk for type 2 diabetes. Radiology 2010; 257: 353-363.
19. Erlingsson S, Herard S, Dahlqvist Leinhard O, Lindström T, Länne T, Borga M, Nyström FH. Men develop more intraabdominal obesity and signs of the metabolic syndrome after hyperalimentation than women. Metabolism 2009; 58: 995-1001.
20. Cesari M, Fielding RA, Pahor M, Goodpaster B, Hellerstein M, Van Kan GA, Anker SD, Rutkove S, Vrijbloed JW, Isaac M, Rolland Y, M'rini C, Aubertin-Leheudre M, Cedarbaum JM, Zamboni M, Sieber CC, Laurent D, Evans WJ, Roubenoff R, Morley JE, Vellas B. Biomarkers of sarcopenia in clinical trials-recommendations from the International Working Group on Sarcopenia. J. Cachexia Sarcopenia Muscle 2012; 3: 181-190.
21. Fischmann A, Hafner P, Fasler S, Gloor M, Bieri O, Studler U, Fischer D. Quantitative MRI can detect subclinical disease progression in muscular dystrophy. J. Neurol. 2012; 259: 1648-1654.
22. Lê KA, Faeh D, Stettler R, Ith M, Kreis R, Vermathen P, Boesch C, Ravussin E, Tappy L. A 4-wk high-fructose diet alters lipid metabolism without affecting insulin sensitivity or ectopic lipids in healthy humans. Am. J. Clin. Nutr. 2006; 84: 1374-1379.
23. Lee S, Boesch C, Kuk JL, Arslanian S. Effects of an overnight intravenous lipid infusion on intramyocellular lipid content and insulin sensitivity in African American versus Caucasian adolescents. Metabolism 2013; 62: 417-423.
24. Zehnder M, Ith M, Kreis R, Saris W, Boutellier U, Boesch C. Gender-specific usage of intramyocellular lipids and glycogen during exercise. Med. Sci. Sports Exerc. 2005; 37: 1517-1524.
25. 1H MRSI before and after prolonged exercise. I. Muscle specific depletion of intramyocellular lipids. Magn. Reson. Med. 2012; 68: 1357-1367.
26. Shen W, Wang Z, Punyanita M, Lei J, Sinav A, Kral JG, Imielinska C, Ross R, Heymsfield SB. Adipose tissue quantification by imaging methods: a proposed classification. Obes. Res. 2003; 11: 5-16.
27. Mattsson S, Thomas BJ. Development of methods for body composition studies. Phys. Med. Biol. 2006; 51: R2*03-R2*28.
28. Seidell JC, Bakker CJ, van der Kooy K. Imaging techniques for measuring adipose-tissue distribution-a comparison between computed tomography and 1.5-T magnetic resonance. Am. J. Clin. Nutr. 1990; 51: 953-957.
29. Goodpaster BH, Thaete FL, Kelley DE. Composition of skeletal muscle evaluated with computed tomography. Ann. N. Y. Acad. Sci. 2000; 904: 18-24.
30. Lubura M, Hesse D, Neumann N, Scherneck S, Wiedmer P, Schurmann A. Non-invasive quantification of white and brown adipose tissues and liver fat content by computed tomography in mice. PLoS One 2012; 7: e37026.
31. Napolitano A, Miller SR, Murgatroyd PR, Coward WA, Wright A, Finer N, De Bruin TW, Bullmore ET, Nunez DJ. Validation of a quantitative magnetic resonance method for measuring human body composition. Obesity (Silver Spring) 2008; 16: 191-198.
32. Schick F, Machann J, Brechtel K, Strempfer A, Klumpp B, Stein DT, Jacob S. MRI of muscular fat. Magn. Reson. Med. 2002; 47: 720-727.
33. Machann J, Thamer C, Schnoedt B, Haap M, Häring HU, Claussen CD, Stumvoll M, Fritsche A, Schick F. Standardized assessment of whole body adipose tissue topography by MRI. J. Magn. Reson. Imaging 2005; 21: 455-462.
34. Siegel MJ, Hildebolt CF, Bae KT, Hong C, White NH. Total and intraabdominal fat distribution in preadolescents and adolescents: measurement with MR imaging. Radiology 2007; 242: 846-856.
35. Kullberg J, Karlsson AK, Stokland E, Svensson PA, Dahlgren J. Adipose tissue distribution in children: automated quantification using water and fat MRI. J. Magn. Reson. Imaging 2010; 32: 204-210.
36. Silver HJ, Niswender KD, Kullberg J, Berglund J, Johansson L, Bruvold M, Avison MJ, Welch EB. Comparison of gross body fat-water magnetic resonance imaging at 3 Tesla to dual-energy X-ray absorptiometry in obese women. Obesity (Silver Spring) 2013; 21: 765-774.
37. Stefan N, Kantartzis K, Machann J, Schick F, Thamer C, Rittig K, Balletshofer B, Machicao F, Fritsche A, Häring HU. Identification and characterization of metabolically benign obesity in humans. Arch. Intern. Med. 2008; 168: 1609-1616.
38. Thomas EL, Parkinson JR, Frost GS, Goldstone AP, Dore CJ, McCarthy JP, Collins AL, Fitzpatrick JA, Durighel G, Taylor-Robinson SD, Bell JD. The missing risk: MRI and MRS phenotyping of abdominal adiposity and ectopic fat. Obesity (Silver Spring) 2012; 20: 76-87.
39. Bitar R, Leung G, Perng R, Tadros S, Moody AR, Sarrazin J, McGregor C, Christakis M, Symons S, Nelson A, Roberts TP. MR pulse sequences: what every radiologist wants to know but is afraid to ask. Radiographics 2006; 26: 513-537.
40. Kellman P, Hernando D, Arai AE. Myocardial fat imaging. Curr. Cardiovasc. Imaging Rep. 2010; 3: 83-91.
41. Shen W, Chen J, Gantz M, Punyanitya M, Heymsfield SB, Gallagher D, Albu J, Engelson E, Kotler D, Pi-Sunyer X, Gilsanz V. MRI-measured pelvic bone marrow adipose tissue is inversely related to DXA-measured bone mineral in younger and older adults. Eur. J. Clin. Nutr. 2012; 66: 983-988.
42. Wittsack HJ, Kapitza C, Cohnen M, Jung G, Heinemann L, Mödder U, Poll L. Interactive thresholded volumetry of abdominal fat using breath-hold T1-weighted magnetic resonance imaging. Rofo 2006; 178: 810-815.
43. Shen W, Wang Z, Tang H, Heshka S, Punyanitya M, Zhu S, Lei J, Heymsfield SB. Volume estimates by imaging methods: model comparisons with visible woman as the reference. Obes. Res. 2003; 11: 217-225.
44. Positano V, Gastaldelli A, Sironi AM, Santarelli MF, Lombardi M, Landini L. An accurate and robust method for unsupervised assessment of abdominal fat by MRI. J. Magn. Reson. Imaging 2004; 20: 684-689.
45. Liou TH, Chan WP, Pan LC, Lin PW, Chou P, Chen CH. Fully automated large-scale assessment of visceral and subcutaneous abdominal adipose tissue by magnetic resonance imaging. Int. J. Obes. (Lond) 2006; 30: 844-852.
46. Kullberg J, Johansson L, Ahlström H, Courivaud F, Koken P, Eggers H, Börnert P. Automated assessment of whole-body adipose tissue depots from continuously moving bed MRI: a feasibility study. J. Magn. Reson. Imaging 2009; 30: 185-193.
47. Dahlqvist Leinhard O, Johansson A, Rydell J, Smedby Ö, Nyström F, Lundberg P, Borga M. Quantitative abdominal fat estimation using MRI. Proceedings of the IEEE 19th International Conference on Pattern Recognition, Tampa, Florida, USA, 2008; 19: 1-4.
48. Wald D, Teucher B, Dinkel J, Kaaks R, Delorme S, Boeing H, Seidensaal K, Meinzer HP, Heimann T. Automatic quantification of subcutaneous and visceral adipose tissue from whole-body magnetic resonance images suitable for large cohort studies. J. Magn. Reson. Imaging 2012; 36: 1421-1434.
49. Würslin C, Springer F, Yang B, Schick F. Compensation of RF field and receiver coil induced inhomogeneity effects in abdominal MR images by a prior knowledge of the human adipose tissue distribution. J. Magn. Reson. Imaging 2011; 34: 716-726.
50. Kullberg J, Angelhed JE, Lonn L, Brandberg J, Ahlström H, Frimmel H, Johansson L. Whole-body T1 mapping improves the definition of adipose tissue: consequences for automated image analysis. J. Magn. Reson. Imaging 2006; 24: 394-401.
51. Maislin G, Ahmed MM, Gooneratne N, Thorne-Fitzgerald M, Kim C, Teff K, Arnardottir ES, Benediktsdottir B, Einarsdottir H, Juliusson S, Pack AI, Gislason T, Schwab RJ. Single slice vs. volumetric MR assessment of visceral adipose tissue: reliability and validity among the overweight and obese. Obesity (Silver Spring) 2012; 20: 2124-2132.
52. Würslin C, Machann J, Rempp H, Claussen C, Yang B, Schick F. Topography mapping of whole body adipose tissue using a fully automated and standardized procedure. J. Magn. Reson. Imaging 2010; 31: 430-439.
53. Mercuri E, Pichiecchio A, Allsop J, Messina S, Pane M, Muntoni F. Muscle MRI in inherited neuromuscular disorders: past, present, and future. J. Magn. Reson. Imaging 2007; 25: 433-440.
54. Garrood P, Hollingsworth KG, Eagle M, Aribisala BS, Birchall D, Bushby K, Straub V. MR imaging in Duchenne muscular dystrophy: quantification of T1-weighted signal, contrast uptake, and the effects of exercise. J. Magn. Reson. Imaging 2009; 30: 1130-1138.
55. Straub V, Pierre G, Mercuri E. TREAT-NMD workshop: pattern recognition in genetic muscle diseases using muscle MRI. Neuromusc. Disord. 2012; 22(Suppl. 2): S42-S53.
56. Huang Y, Majumdar S, Genant HK, Chan WP, Sharma KR, Yu P, Mynhier M, Miller RG. Quantitative MR relaxometry study of muscle composition and function in Duchenne muscular dystrophy. J. Magn. Reson. Imaging 1994; 4: 59-64.
57. Phoenix J, Betal D, Roberts N, Helliwell TR, Edwards RH. Objective quantification of muscle and fat in human dystrophic muscle by magnetic resonance image analysis. Muscle Nerve 1996; 19: 302-310.
58. Kan HE, Scheenen TW, Wohlgemuth M, Klomp DW, van Loosbroek-Wagenmans I, Padberg GW, Heerschap A. Quantitative MR imaging of individual muscle involvement in facioscapulohumeral muscular dystrophy. Neuromuscul. Disord. 2009; 19: 357-362.
59. Friedman SD, Poliachik SL, Carter GT, Budech CB, Bird TD, Shaw DW. The magnetic resonance imaging spectrum of facioscapulohumeral muscular dystrophy. Muscle Nerve 2012; 45: 500-506.
60. Strobel K, van den Hoff J, Pietzsch J. Localized proton magnetic resonance spectroscopy of lipids in adipose tissue at high spatial resolution in mice in vivo. J. Lipid Res. 2008; 49: 473-480.
61. 1H MR spectrum. NMR Biomed. 2011; 24: 784-790.
62. Berglund J, Ahlström H, Kullberg J. Model-based mapping of fat unsaturation and chain length by chemical shift imaging-phantom validation and in vivo feasibility. Magn. Reson. Med. 2012; 68: 1815-1827.
63. Petersen P, Måsson S. Simultaneous quantification of fat content and fatty acid composition using MR imaging. Magn. Reson. Med. 2013; 69: 688-697.
64. Sharma P, Martin DR, Pineda N, Xu Q, Vos M, Anania F, Hu X. Quantitative analysis of T2*-correction in single-voxel magnetic resonance spectroscopy of hepatic lipid fraction. J. Magn. Reson. Imaging 2009; 29: 629-635.
65. 1H-magnetic resonance spectroscopy study. Circulation 2007; 116: 1170-1175.
66. Lingvay I, Esser V, Legendre JL, Price AL, Wertz KM, Adams-Huet B, Zhang S, Unger RH, Szczepaniak LS. Noninvasive quantification of pancreatic fat in humans. J. Clin. Endocrinol. Metab. 2009; 94: 4070-4076.
67. 1H NMR spectroscopy study. Diabetologia 1999; 42: 113-116.
68. 1H nuclear magnetic resonance spectroscopy in lean and obese adolescents: relationships to insulin sensitivity, total body fat, and central adiposity. Diabetes 2002; 51: 1022-1027.
69. Boesch C, Machann J, Vermathen P, Schick F. Role of proton MR for the study of muscle lipid metabolism. NMR Biomed. 2006; 19: 968-988.
70. Weis J, Johansson L, Ortiz-Nieto F, Ahlström H. Assessment of lipids in skeletal muscle by high-resolution spectroscopic imaging using fat as the internal standard: comparison with water referenced spectroscopy. Magn. Reson. Med. 2008; 59: 1259-1265.
71. Fischer MA, Nanz D, Shimakawa A, Schirmer T, Guggenberger R, Chhabra A, Carrino JA, Andreisek G. Quantification of muscle fat in patients with low back pain: comparison of multi-echo MR imaging with single-voxel MR spectroscopy. Radiology 2013; 256: 555-563.
72. 1H MR spectroscopy of hip bone marrow in a healthy population, assessment of normal fat content values and influence of age and sex. J. Magn. Reson. Imaging 2013; DOI: 10.1002/jmri.24176.
73. Karampinos DC, Melkus G, Baum T, Bauer JS, Rummeny EJ, Krug R. Bone marrow fat quantification in the presence of trabecular bone: initial comparison between water-fat imaging and single-voxel MRS. Magn. Reson. Med. 2013; DOI: 10.1002/mrm.24775.
74. Månsson S, Peterson P, Johansson E. Quantification of low fat contents: a comparison of MR imaging and spectroscopy methods at 1.5 and 3T. Magn. Reson. Imaging 2012; 30: 1461-1467.
75. 1H MR-chemical shift imaging. Magn. Reson. Med. 2001; 46: 879-883.
76. 1H NMR at 7 Tesla. J. Lipid Res. 2008; 49: 2055-2062.
77. Naressi A, Couturier C, Castang I, de Beer R, Graveron-Demilly D. Java-based graphical user interface for MRUI, a software package for quantitation of in vivo/medical magnetic resonance spectroscopy signals. Comput. Biol. Med. 2001; 31: 269-286.
78. 1H spectra with LCModel. NMR Biomed. 2001; 14: 260-264.
79. Bydder M, Hamilton G, Yokoo T, Sirlin CB. Optimal phased-array combination for spectroscopy. Magn. Reson. Imaging 2008; 26: 847-850.
80. An L, Willem van der Veen J, Li S, Thomasson DM, Shen J. Combination of multichannel single-voxel MRS signals using generalized least squares. J. Magn. Reson. Imaging 2013; 37: 1445-1450.
81. Felblinger J, Jung B, Slotboom J, Boesch C, Kreis R. Methods and reproducibility of cardiac/respiratory double-triggered (1)H-MR spectroscopy of the human heart. Magn. Reson. Med. 1999; 42: 903-910.
82. Schär M, Kozerke S, Boesiger P. Navigator gating and volume tracking for double-triggered cardiac proton spectroscopy at 3 Tesla. Magn. Reson. Med. 2004; 51: 1091-1095.
83. Frahm J, Bruhn H, Gyngell ML, Merboldt KD, Hanicke W, Sauter R. Localized high-resolution proton NMR spectroscopy using stimulated echoes: initial applications to human brain in vivo. Magn. Reson. Med. 1989; 9: 79-93.
84. Bottomley PA. Spatial localization in NMR spectroscopy in vivo. Ann. N. Y. Acad. Sci. 1987; 508: 333-348.
85. Goelman G, Liu S, Fleyscher R, Fleysher L, Grossman RI, Gonen O. Chemical-shift artifact reduction in hadamard-encoded MR spectroscopic imaging at high (3T and 7T) magnetic fields. Magn. Reson. Med. 2007; 58: 167-173.
86. 1H-MRSI of the human brain at 3T with minimal chemical shift displacement errors using adiabatic refocusing pulses. Magn. Reson. Med. 2008; 59: 1-6.
87. 1H MRS at 7T. Magn. Reson. Med. 2013; 69: 603-612.
88. Hu HH, Kim HW, Nayak KS, Goran MI. Comparison of fat-water MRI and single-voxel MRS in the assessment of hepatic and pancreatic fat fractions in humans. Obesity (Silver Spring) 2010; 18: 841-847.
89. 1H-magnetic resonance spectroscopy. Ann. N. Y. Acad. Sci. 2000; 904: 25-31.
90. Posse S, Otazo R, Dager SR, Alger J. MR spectroscopic imaging: principles and recent advances. J. Magn. Reson. Imaging 2013; 37: 1301-1325.
91. Lin FH, Tsai SY, Otazo R, Caprihan A, Wald LL, Belliveau JW, Posse S. Sensitivity-encoded (SENSE) proton echo-planar spectroscopic imaging (PEPSI) in the human brain. Magn. Reson. Med. 2007; 57: 249-257.
92. 13C studies. Magn. Reson. Med. 2011; 65: 610-619.
93. Furuyama JK, Wilson NE, Burns BL, Nagarajan R, Margolis DJ, Thomas MA. Application of compressed sensing to multidimensional spectroscopic imaging in human prostate. Magn. Reson. Med. 2012; 67: 1499-1505.
94. Mareci TH, Brooker HR. Essential considerations for spectral localization using indirect gradient encoding of spatial information. J. Magn. Reson. 1991; 92: 229-246.
95. Le Roux P, Gilles RJ, McKinnon GC, Carlier PG. Optimized outer volume suppression for single-shot fast spin-echo cardiac imaging. J. Magn. Reson. Imaging 1998; 8: 1022-1032.
96. Scheenen TW, Klomp DW, Roll SA, Futterer JJ, Barentsz JO, Heerschap A. Fast acquisition-weighted three-dimensional proton MR spectroscopic imaging of the human prostate. Magn. Reson. Med. 2004; 52: 80-88.
97. Schick F, Eismann B, Jung WI, Bongers H, Bunse M, Lutz O. Comparison of localized proton NMR signals of skeletal muscle and fat tissue in vivo: two lipid compartments in muscle tissue. Magn. Reson. Med. 1993; 29: 158-167.
98. Boesch C. Musculoskeletal spectroscopy. J. Magn. Reson. Imaging 2007; 25: 321-338.
99. Khuu A, Ren J, Dimitrov I, Woessner D, Murdoch J, Sherry AD, Malloy CR. Orientation of lipid strands in the extracellular compartment of muscle: effect on quantitation of intramyocellular lipids. Magn. Reson. Med. 2009; 61: 16-21.
100. 1H MRS of intramyocellular lipids in soleus muscle at 7T: spectral simplification by using long echo times without water suppression. Magn. Reson. Med. 2010; 64: 662-671.
101. Ortiz-Nieto F, Johansson L, Ahlström H, Weis J. Quantification of lipids in human lower limbs using yellow bone marrow as the internal reference: gender-related effects. J. Magn. Reson. Imaging 2010; 28: 676-682.
102. Schrauwen-Hinderling VB, van Loon LJ, Koopman R, Nicolay K, Saris WH, Kooi ME. Intramyocellular lipid content is increased after exercise in nonexercising human skeletal muscle. J. Appl. Physiol. 2003; 95: 2328-2332.
103. Bachmann OP, Dahl DB, Brechtel K, Machann J, Haap M, Maier T, Loviscach M, Stumvoll M, Claussen CD, Schick F, Häring HU, Jacob S. Effects of intravenous and dietary lipid challenge on intramyocellular lipid content and the relation with insulin sensitivity in humans. Diabetes 2001; 50: 2579-2584.
104. Zehnder M, Christ ER, Ith M, Acheson KJ, Pouteau E, Kreis R, Trepp R, Diem P, Boesch C, Décombaz J. Intramyocellular lipid stores increase markedly in athletes after 1.5days lipid supplementation and are utilized during exercise in proportion to their content. Eur. J. Appl. Physiol. 2006; 98: 341-354.
105. 13C] magnetic resonance spectroscopy. Magn. Reson. Med. 2012; 68: 997-1006.
106. Goodpaster BH, He J, Watkins S, Kelley DE. Skeletal muscle lipid content and insulin resistance: evidence for a paradox in endurance-trained athletes. J. Clin. Endocrinol. Metab. 2001; 86: 5755-5761.
107. Wijsman CA, van Opstal AM, Kan HE, Maier AB, Westendorp RG, Slagboom PE, Webb AG, Mooijaart SP, van Heemst D. Proton magnetic resonance spectroscopy shows lower intramyocellular lipid accumulation in middle-aged subjects predisposed to familial longevity. Am. J. Physiol. Endocrinol. Metab. 2012; 302: E344-E348.
108. Décombaz J, Schmitt B, Ith M, Decarli B, Diem P, Kreis R, Hoppeler H, Boesch C. Postexercise fat intake repletes intramyocellular lipids but no faster in trained than in sedentary subjects. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2001; 281: R760-R769.
109. 1H NMR chemical shift selective (CHESS) imaging. Phys. Med. Biol. 1985; 30: 341-344.
110. Meyer CH, Pauly JM, Makovski A, Nishimura DG. Simultaneous spatial and spectral selective excitation. Magn. Reson. Med. 1990; 15: 287-304.
111. Kaldoudi E, Williams SC, Barker GJ, Tofts PS. A chemical shift selective inversion recovery sequence for fat-suppressed MRI: theory and experimental validation. Magn. Reson. Imaging 1993; 11: 341-355.
112. Block W, Pauly JM, Kerr A, Nishimura DG. Consistent fat suppression with compensated spectral-spatial pulses. Magn. Reson. Med. 1997; 38: 198-206.
113. Schick F. Simultaneous highly selective MR water and fat imaging using a simple new type of spectral-spatial excitation. Magn. Reson. Med. 1998; 40: 194-202.
114. Laurent WM, Bonny JM, Renou JP. Imaging of water and fat fractions in high-field MRI with multiple slice chemical shift-selective inversion recovery. J. Magn. Reson. Imaging 2000; 12: 488-496.
115. Machann J, Bachmann OP, Brechtel K, Dahl DB, Wietek B, Klumpp B, Häring HU, Claussen CD, Jacob S, Schick F. Lipid content in the musculature of the lower leg assessed by fat selective MRI: intra- and interindividual differences and correlation with anthropometric and metabolic data. J. Magn. Reson. Imaging 2003; 17: 350-357.
116. Peng Q, McColl RW, Wang J, Chia JM, Weatherall PT. Water-saturated three-dimensional balanced steady-state free precession for fast abdominal fat quantification. J. Magn. Reson. Imaging 2005; 21: 263-271.
117. Makrogiannis S, Serai S, Fishbein KW, Schreiber C, Ferrucci L, Spencer RG. Automated quantification of muscle and fat in the thigh from water-, fat-, and nonsuppressed MR images. J. Magn. Reson. Imaging 2012; 35: 1152-1161.
118. 1H-MR spectroscopy. Magn. Reson. Med. 2006; 55: 913-917.
119. Schwenzer NF, Machann J, Martirosian P, Stefan N, Schraml C, Fritsche A, Claussen CD, Schick F. Quantification of pancreatic lipomatosis and liver steatosis by MRI: comparison of in/opposed-phase and spectral-spatial excitation techniques. Invest. Radiol. 2008; 43: 330-337.
120. Raschpichler MC, Sorge I, Hirsch W, Mende M, Sergeyev E, Kruber D, Koerner A, Schick F. Evaluating childhood obesity: magnetic resonance-based quantification of abdominal adipose tissue and liver fat in children. Rofo 2012; 184: 324-332.
121. Delfaut EM, Beltran J, Johnson G, Rousseau J, Marchandise X, Cotton A. Fat suppression in MR imaging: techniques and pitfalls. Radiographics 1999; 19: 373-382.
122. Ma J. Dixon techniques for water and fat imaging. J. Magn. Reson. Imaging 2008; 28: 543-558.
123. Bley TA, Wieben O, Francois CJ, Brittain JH, Reeder SB. Fat and water magnetic resonance imaging. J. Magn. Reson. Imaging 2010; 31: 4-18.
124. An L, Xiang QS. Chemical shift imaging with spectrum modeling. Magn. Reson. Med. 2001; 46: 126-130.
125. Yu H, McKenzie CA, Brodsky E, Brittain JH, Reeder SB. Multiecho water-fat separation and simultaneous R2*estimation with multifrequency fat spectrum modeling. Magn. Reson. Med. 2008; 60: 1122-1134.
126. Dixon WT. Simple proton spectroscopic imaging. Radiology 1984; 153: 189-194.
127. Sepponen RE, Sipponen JT, Tanttu JI. A method for chemical shift imaging: demonstration of bone marrow involvement with proton chemical shift imaging. J. Comput. Assist. Tomogr. 1984; 8: 585-587.
128. 1H spectral images. Invest. Radiol. 1985; 20: 845-853.
129. Cassidy FH, Yokoo T, Aganovic L, Hanna RF, Bydder M, Middleton MS, Hamilton G, Chavez AD, Schwimmer JB, Sirlin CB. Fatty liver disease: MR imaging techniques for the detection and quantification of liver steatosis. Radiographics 2009; 29: 231-260.
130. Hussain HK, Chenevert TL, Londy FJ, Gulani V, Swanson SD, McKenna BJ, Appelman HD, Adusumilli S, Greenson JK, Conjeevaram HS. Hepatic fat fraction: MR imaging for quantitative measurement and display-early experience. Radiology 2005; 237: 1048-1055.
131. Börnert P, Keupp J, Eggers H, Aldefeld B. Whole-body 3D water/fat resolved continuously moving table imaging. J. Magn. Reson. Imaging 2007; 25: 660-665.
132. Berglund J, Johansson L, Ahlström H, Kullberg J. Three-point Dixon method enables whole-body water and fat imaging of obese subjects. Magn. Reson. Med. 2010; 63: 1659-1668.
133. Boll DT, Marin D, Redmon GM, Zink SI, Merkle EM. Pilot study assessing differentiation of steatosis hepatis, hepatic iron overload, and combined disease using two-point Dixon MRI at 3T: in vitro and in vivo results of a 2D decomposition technique. Am. J. Roentgenol. 2010; 194: 964-971.
134. Gloor M, Fasler S, Fischmann A, Haas T, Bieri O, Heinimann K, Wetzel SG, Scheffler K, Fischer D. Quantification of fat infiltration in oculopharyngeal muscular dystrophy: comparison of three MR imaging methods. J. Magn. Reson. Imaging 2011; 33: 203-210.
135. Gaeta M, Messina S, Mileto A, Vita GL, Ascenti G, Vinci S, Bottari A, Vita G, Settineri N, Bruschetta D, Racchiusa S, Minutoli F. Muscle fat-fraction and mapping in Duchenne muscular dystrophy: evaluation of disease distribution and correlation with clinical assessments: preliminary experience. Skel. Radiol. 2012; 41: 955-961.
136. Hollingsworth KG, de Sousa PL, Straub V, Carlier PG. Towards harmonization of protocols for MRI outcome measures in skeletal muscle studies: consensus recommendations from two TREAT-NMD NMR workshops, 2 May 2010, Stockholm, Sweden, 1-2 October 2009, Paris, France. Neuromuscul. Disord. 2012; 22(Suppl. 2): S54-S67.
137. Karampinos DC, Baum T, Nardo L, Alizai H, Yu H, Carballido-Gamio J, Yap SP, Shimakawa A, Link TM, Majumdar S. Characterization of the regional distribution of skeletal muscle adipose tissue in type 2 diabetes using chemical shift-based water/fat separation. J. Magn. Reson. Imaging 2012; 35: 899-907.
138. Poonawalla AH, Sjoberg BP, Rehm JL, Hernando D, Hines CD, Irarrazaval P, Reeder SB. Adipose tissue MRI for quantitative measurement of central obesity. J. Magn. Reson. Imaging 2013; 37: 707-716.
139. Wokke BH, Bos C, Reijnierse M, van Rijswijk CS, Eggers H, Webb A, Verschuuren JJ, Kan HE. Comparison of Dixon and T1-weighted MR methods to assess the degree of fat infiltration in Duchenne muscular dystrophy patients. J. Magn. Reson. Imaging 2013; 38: 619-624.
140. Karampinos DC, Melkus G, Baum T, Bauer JS, Rummeny EJ, Krug R. Bone marrow fat quantification in the presence of trabecular bone: initial comparison between water-fat imaging and single-voxel MRS. Magn. Reson. Med. 2013; DOI: 10.1002/mrm.24775.
141. Eggers H, Brendel B, Duijndam A, Herigault G. Dual-echo Dixon imaging with flexible choice of echo times. Magn. Reson. Med. 2011; 65: 96-107.
142. Berglund J, Ahlström H, Johansson L, Kullberg J. Two-point Dixon method with flexible echo times. Magn. Reson. Med. 2011; 65: 994-1004.
143. Hernando D, Kellman P, Haldar JP, Liang ZP. Robust water/fat separation in the presence of large field inhomogeneities using a graph cut algorithm. Magn. Reson. Med. 2010; 63: 79-90.
144. Berglund J, Kullberg J. Three-dimensional water/fat separation and T2*estimation based on whole-image optimization-application in breathhold liver imaging at 1.5T. Magn. Reson. Med. 2012; 67: 1684-1693.
145. Tsao J, Jiang Y. Hierarchical IDEAL: fast, robust, and multiresolution separation of multiple chemical species from multiple echo times. Magn. Reson. Med. 2013; 70: 155-159.
146. Hernando D, Liang ZP, Kellman P. Chemical shift-based water/fat separation: a comparison of signal models. Magn. Reson. Med. 2010; 64: 811-822.
147. Karampinos DC, Yu H, Shimakawa A, Link TM, Majumdar S. Chemical shift-based water/fat separation in the presence of susceptibility-induced fat resonance shift. Magn. Reson. Med. 2012; 68: 1495-1505.
148. Peterson P, Månsson S. Fat quantification using multi-echo sequences with bipolar gradients: investigation of accuracy and noise performance. Magn. Reson. Med. 2013; DOI: 10.1002/mrm.24657.
149. Horng DE, Hernando D, Hines CD, Reeder SB. Comparison of R2* correction methods for accurate fat quantification in fatty liver. J. Magn. Reson. Imaging 2013; 37: 414-422.
150. Wood JC, Enriquez C, Ghugre N, Tyzka JM, Carson S, Nelson MD, Coates TD.
151. Storey P, Thompson AA, Carqueville CL, Wood JC, de Freitas RA, Rigsby CK. R2*imaging of transfusional iron burden at 3T and comparison with 1.5T. J. Magn. Reson. Imaging 2007; 25: 540-547.
152. Taylor BA, Loeffler RB, Song R, McCarville MB, Hankins JS, Hillenbrand CM. Simultaneous field and R2*mapping to quantify liver iron content using autoregressive moving average modeling. J. Magn. Reson. Imaging 2012; 35: 1125-1132.
153. Hernando D, Kramer JH, Reeder SB. Multipeak fat-corrected complex R2*relaxometry: theory, optimization and clinical validation. Magn. Reson. Med. 2013; DOI: 10.1002/mrm.24593.
154. Hines CD, Frydrychowicz A, Hamilton G, Tudorascu DL, Vigen KK, Yu H, McKenzie CA, Sirlin CB, Brittain JH, Reeder SB. T1 independent, T2*corrected chemical shift based fat-water separation with multi-peak fat spectral modeling is an accurate and precise measure of hepatic steatosis. J. Magn. Reson. Imaging 2011; 33: 873-881.
155. Meisamy S, Hines CD, Hamilton G, Sirlin CB, McKenzie CA, Yu H, Brittain JH, Reeder SB. Quantification of hepatic steatosis with T1-independent, T2*-corrected MR imaging with spectral modeling of fat: blinded comparison with MR spectroscopy. Radiology 2011; 258: 767-775.
156. Tang A, Tan J, Sun M, Hamilton G, Bydder M, Wolfson T, Gamst AC, Middleton M, Brunt EM, Loomba R, Lavine JE, Schwimmer JB, Sirlin CB. Nonalcoholic fatty liver disease: MR imaging of liver proton density fat fraction to assess hepatic steatosis. Radiology 2013; 267: 422-431.
157. Liu CY, McKenzie CA, Yu H, Brittain JH, Reeder SB. Fat quantification with IDEAL gradient echo imaging: correction of bias from T1 and noise. Magn. Reson. Med. 2007; 58: 354-364.
158. Bydder M, Yokoo T, Hamilton G, Middleton MS, Chavez AD, Schwimmer JB, Lavine JE, Sirlin CB. Relaxation effects in the quantification of fat using gradient echo imaging. Magn. Reson. Imaging 2008; 26: 347-359.
159. Reeder SB, Hu HH, Sirlin CB. Proton density fat-fraction: a standardized MR-based biomarker of tissue fat concentration. J. Magn. Reson. Imaging 2012; 36: 1011-1014.
160. Mashhood A, Railkar R, Yokoo T, Levin Y, Clark L, Fox-Bosetti S, Middleton MS, Riek J, Kauh E, Dardzinski BJ, Williams D, Sirlin C, Shire NJ. Reproducibility of hepatic fat fraction measurement by magnetic resonance imaging. J. Magn. Reson. Imaging 2013; 37: 1359-1370.
161. Frontini A, Cinti S. Distribution and development of brown adipocytes in the murine and human adipose organ. Cell Metab. 2010; 11: 253-256.
162. Ravussin E, Galgani JE. The implication of brown adipose tissue for humans. Annu. Rev. Nutr. 2011; 31: 33-47.
163. Wronska A, Kmiec Z. Structural and biochemical characteristics of various white adipose tissue depots. Acta Physiol (Oxf.) 2012; 205: 194-208.
164. Nedergaard J, Bengtsson T, Cannon B. Three years with adult human brown adipose tissue. Ann. N. Y. Acad. Sci. 2010; 1212: E20-E36.
165. Lee P, Swarbrick MM, Ho KK. Brown adipose tissue in adult humans: a metabolic renaissance. Endocrin. Rev. 2013; 34: 413-438.
166. Ouellet V, Labbe SM, Blondin DP, Phoenix S, Guerin B, Haman F, Turcotte EE, Richard D, Carpentier AC. Brown adipose tissue oxidative metabolism contributes to energy expenditure during acute cold exposure in humans. J. Clin. Invest. 2012; 122: 545-552.
167. 15O PET measurement of blood flow and oxygen consumption in cold-activated human brown fat. J. Nucl. Med. 2013; 54: 523-531.
168. Cannon B, Nedergaard J. Brown adipose tissue: function and physiological significance. Physiol. Rev. 2004; 84: 277-359.
169. Cinti S. The role of brown adipose tissue in human obesity. Nutr. Metab. Cardiovasc. Dis. 2006; 16: 569-574.
170. Aherne W, Hull D. Brown adipose tissue and heat production in the newborn infant. J. Pathol. Bacteriol. 1996; 91: 223-234.
171. Heaton JM. The distribution of brown adipose tissue in the human. J. Anat. 1972; 112: 35-39.
172. Merklin RJ. Growth and distribution of human fetal brown fat. Anat. Rec. 1974; 178: 637-645.
173. Mortola JP, Merazzi D, Naso L. Blood flow to the brown adipose tissue of conscious young rabbits during hypoxia in cold and warm conditions. Pflugers Arch. 1999; 437: 225-260.
174. Da Motta AC, Tunkel DE, Westra WH, Yousem DM. Imaging findings of a hibernoma of the neck. Am. J. Neuroradiol. 2006; 27: 1658-1659.
175. Mavrogenis AF, Coll-Mesa L, Drago G, Gambarotti M, Ruggieri P. Hibernomas: clinicopathological features, diagnosis, and treatment of 17 cases. Orthopedics 2011; 34: e755-e759.
176. Kumar R, Deaver MT, Czemiak BA, Madwell JE. Intraosseous hibernoma. Skel. Radiol. 2011; 40: 641-645.
177. Papathanassiou ZG, Alberghini M, Taieb S, Errani C, Picci P, Vanel D. Imaging of hibernomas: a retrospective study on twelve cases. Clin. Sarcoma Res. 2011; 1: 3.
178. Elqatni M, Ghafir D. Hibernoma of the neck. N. Engl. J. Med. 2012; 367: 1636.
179. Dundamadappa SK, Shankar S, Danrad R, Singh A, Vijayaraghavan G, Kim Y, Perugini R. Imaging of brown fat associated with adrenal pheochromocytoma. Acta Radiol. 2007; 48: 468-472.
180. Carter BW, Schucany WG. Brown adipose tissue in a newborn. Proc. (Bayl. Univ. Med. Cent.) 2008; 21: 328-330.
181. Osculati F, Leclercq F, Sbarbati A, Zancanaro C, Cinti S, Antonakis K. Morphological identification of brown adipose tissue by magnetic resonance imaging in the rat. Eur. J. Radiol. 1989; 9: 112-114.
182. Osculati F, Sbarbati A, Leclercq F, Zancanaro C, Accordini C, Antonakis K, Boicelli A, Cinti S. The correlation between magnetic resonance imaging and ultrastructural patterns of brown adipose tissue. J. Submicrosc. Cytol. Pathol. 1991; 23: 167-174.
183. Sbarbati A, Baldassarri AM, Zancanaro C, Boicelli A, Osculati F. In vivo morphometry and functional morphology of brown adipose tissue by magnetic resonance imaging. Anat. Rec. 1991; 231: 293-297.
184. Chen YI, Cypess AM, Sass CA, Brownell AL, Jokivarsi KT, Kahn CR, Kwong KK. Anatomical and functional assessment of brown adipose tissue by magnetic resonance imaging. Obesity (Silver Spring) 2012; 20: 1519-1526.
185. Hamilton G, Smith DL, Jr, Bydder M, Nayak KS, Hu HH. MR properties of brown and white adipose tissues. J. Magn. Reson. Imaging 2011; 34: 468-473.
186. Zancanaro C, Nano R, Marchioro C, Sbarbati A, Boicelli A, Osculati F. Magnetic resonance spectroscopy investigations of brown adipose tissue and isolated brown adipocytes. J. Lipid Res. 1994; 35: 2191-2199.
187. Sbarbati A, Guerrini U, Marzola P, Asperio R, Osculati F. Chemical shift imaging at 4.7 Tesla of brown adipose tissue. J. Lipid Res. 1997; 38: 343-347.
188. Lunati E, Marzola P, Nicolato E, Fedrigo M, Villa M, Sbarbati A. In vivo quantitative lipidic map of brown adipose tissue by chemical shift imaging at 4.7 Tesla. J. Lipid Res. 1999; 40: 1395-1400.
189. 1H MR spectroscopy. Am. J. Physiol. Endocrinol. Metab. 2013; 304: E160-E167.
190. Hu HH, Smith DL, Jr, Nayak KS, Goran MI, Nagy TR. Identification of brown adipose tissue in mice with fat-water IDEAL-MRI. J. Magn. Reson. Imaging 2010; 31: 1195-1202.
191. Hu HH, Hines CD, Smith DL, Jr, Reeder SB. Variations in T2*and fat content of murine brown and white adipose tissues by chemical-shift MRI. Magn. Reson. Imaging 2012; 30: 323-329.
192. Smith DL, Yang Y, Hu HH, Zhai G, Nagy TR. Measurement of interscapular brown adipose tissue of mice in differentially housed temperatures by chemical-shift-encoded water-fat magnetic resonance imaging. J. Magn. Reson. Imaging 2013; DOI: 10.1002/jmri.24138.
193. Holstila M, Virtanen KA, Grönroos TV, Laine J, Lepomäki V, Saunavaara J, Lisinen I, Komu M, Hannukainen H, Nuutila P, Parkkola R, Borra RJH. Measurement of brown adipose tissue mass using a novel dual-echo magnetic resonance imaging approach: a validation study. Metabolism 2013; 62: 1189-1198.
194. Hu HH, Tovar JP, Pavlova Z, Smith ML, Gilsanz V. Unequivocal identification of brown adipose tissue in a human infant. J. Magn. Reson. Imaging 2012; 35: 938-942.
195. Hu HH, Perkins TG, Chia JM, Gilsanz V. Characterization of human brown adipose tissue by chemical-shift water-fat MRI. Am. J. Roentgenol. 2013; 200: 177-183.
196. Hu HH, Yin L, Aggabao PC, Perkins TG, Chia JM, Gilsanz V. Comparison of brown and white adipose tissues in infants and children with chemical-shift-encoded water-fat MRI. J. Magn. Reson. Imaging 2013; DOI: 10.1002/jmri.24053.
197. Lidell ME, Betz MJ, Dahlqvist Leinhard O, Heglind M, Elander L, Slawik M, Mussack T, Nilsson D, Romu T, Nuutila P, Virtanen KA, Beuschlein F, Persson A, Borga M, Enerbäck S. Evidence of two types of brown adipose tissue in humans. Nat. Med. 2013; 19: 631-634.
198. Gifford A, Kullberg J, Berglund J, Towse TF, Walker RC, Avison MJ, Welch EB. Detection of brown adipose tissue in an adult human using fat-water MRI with validation by cold-activated PET. Proceedings of the 21st Annual Meeting ISMRM, Salt Lake City, Utah, USA, 2013; 1520.
199. Wayte SC, Reddy NL, Jones TA, Adesanya O, Yoe YC, Randeva HS, Kumar S, Hutchinson CE, Barber TM. Identification of brown adipose tissue using Dixon imaging in a human adult with histological confirmation. Proceedings of the 21st Annual Meeting ISMRM, Salt Lake City, Utah, USA, 2013; 4052.
200. Lundström E, Berglund J, Johansson L, Bergsten P, Ahlström H, Kullberg J. Water-fat imaging of supraclavcular brown and white adipose tissue at 1.5T: initial results in healthy volunteers. Proceedings of the 21st Annual Meeting ISMRM, Salt Lake City, Utah, USA, 2013; 4050.
201. 18F]fluoro-D-glucose positron emission tomography. Invest. Radiol. 2013; 48: 708-714.
202. Branca RT, Warren WS. In vivo brown adipose tissue detection and characterization using water-lipid intermolecular zero-quantum coherences. Magn. Reson. Med. 2011; 65: 313-319.
203. Bao J, Cui X, Cai S, Zhong J, Cai C, Chen Z. Brown adipose tissue mapping in rats with combined intermolecular double-quantum coherence and Dixon water-fat MRI. NMR Biomed. 2013; DOI: 10.1002/nbm.3000.
204. Hu HH, Nagy TR, Li Y, Goran MI, Nayak KS. Quantification of absolute fat mass by magnetic resonance imaging: a validation study against chemical assay. Int. J. Body Composition Res. 2011; 9: 111-122.
205. Joshi AA, Hu HH, Goran MI, Leahy RM, Nayak KS. Automatic intra-subject registration-based segmentation of abdominal fat from 3D water-fat MRI. J. Magn. Reson. Imaging 2013; 37: 423-430.
206. Thörmer G, Bertram HH, Garnov N, Peter V, Schütz TS, Hang E, Büher M, Kahn T, Busse H. Software for automated MRI-based quantification of abdominal fat and preliminary evaluation in morbidly obese patients. J. Magn. Reson. Imaging 2013; 37: 1140-1150.
207. Brunner G, Nambia V, Yang E, Kumar A, Virani SS, Kougias P, Shah D, Lumsden A, Ballantyne CM, Morrisett JD. Automatic quantification of muscle volumes in magnetic resonance imaging scans of the lower extremities. Magn. Reson. Imaging 2011; 29: 1065-1075.
208. Commean PK, Tuttle LJ, Hastings MK, Strube MJ, Mueller MJ. Magnetic resonance imaging measurement reproducibility for calf muscle and adipose tissue volume. J. Magn. Reson. Imaging 2011; 34: 1285-1294.
209. Hiba B, Richard N, Hébert LJ, Coté C, Nejjari M, Vial C, Bouhour F, Puymirat J, Janier M. Quantitative assessment of skeletal muscle degeneration in patients with myotonic dystrophy type 1 using MRI. J. Magn. Reson. Imaging 2012; 35: 678-685.
210. Valentinitsch A, Karampinos DC, Alizai H, Subburaj K, Kumar D, Link TM, Majumdar S. Automated unsupervised multi-parametric classification of adipose tissue depots in skeletal muscle. J. Magn. Reson. Imaging 2013; 37: 917-927.
211. Sinha S, SInha U, Edgerton VR. In vivo diffusion tensor imaging of the human calf muscle. J. Magn. Reson. Imaging 2006; 24: 182-190.
212. Williams SE, Heemskerk AM, Welch EB, Li K, Damon BM, Park JH. Quantitative effects of inclusion of fat on muscle diffusion tensor MRI measurements. J. Magn. Reson. Imaging 2013; DOI: 10.1002/jmri.24045.
213. Walker GE, Verti B, Marzullo P, Savia G, Mencarelli M, Zurleni F, Liuzzi A, Di Blasio AM. Deep subcutaneous adipose tissue: a distinct abdominal adipose depot. Obesity (Silver Spring) 2007; 15: 1933-1943.
214. Kelley DE, Thaete FL, Troost F, Huwe T, Goodpaster BH. Subdivisions of subcutaneous abdominal adipose tissue and insulin resistance. Am. J. Physiol. Endocrinol. Metab. 2000; 278: E941-E948.
215. Lundbom J, Hakkarainen A, Lundbom N, Taskinen MR. Deep subcutaneous adipose tissue is more saturated than superficial subcutaneous adipose tissue. Int. J. Obes. (Lond) 2013; 37: 620-622.
216. 1H-MRS. Proceedings of the 21st Annual Meeting ISMRM, Salt Lake City, Utah, USA, 2013; 1511.
217. Bydder M, Girard O, Hamilton G. Mapping the double bonds in triglycerides. Magn. Reson. Imaging 2011; 29: 1041-1046.
218. Pou KM, Massaro JM, Hoffmann U, Vasan RS, Maurovich-Horvat P, Larson MG, Keaney JF, Jr, Meigs JB, Lipinska I, Kathiresan S, Murabito JM, O'Donnell CJ, Benjamin EJ, Fox CS. Visceral and subcutaneous adipose tissue volumes are cross-sectionally related to markers of inflammation and oxidative stress: the Framingham Heart Study. Circulation 2007; 116: 1234-1241.
219. Tchoukalova YD, Koutsari C, Karpyak MV, Votruba SB, Wendland E, Jensen MD. Subcutaneous adipocyte size and body fat distribution. Am. J. Clin. Nutr. 2008; 87: 56-63.
220. Spalding KL, Arner E, Westermark PO, Bernard S, Buchholz BA, Bergmann O, Blomqvist L, Hoffstedt J, Näslund E, Britton T, Concha H, Hassan M, Rydén M, Frisén J, Arner P. Dynamics of fat cell turnover in humans. Nature 2008; 453: 783-787.
221. Weyer C, Foley JE, Bogardus C, Tataranni PA, Pratley RE. Enlarged subcutaneous abdominal adipocyte size, but not obesity itself, predicts type II diabetes independent of insulin resistance. Diabetologia 2000; 43: 1498-1506.
222. Kabir M, Stefanovski D, Hsu IR, Iyer M, Woolcott OO, Zheng D, Catalano KJ, Chiu JD, Kim SP, Harrison LN, Ionut V, Lottati M, Bergman RN, Richey JM. Large size cells in the visceral adipose depot predict insulin resistance in the canine model. Obesity (Silver Spring) 2011; 19: 2121-2129.
223. Khurana A, Nejadnik H, Gawande R, Lin G, Lee S, Messing S, Castaneda R, Derugin N, Pisani L, Lue TF, Daldrup-Link HE. Intravenous Ferumoxytol allows noninvasive MR imaging monitoring of macrophage migration into stem cell transplants. Radiology 2012; 264: 803-811.
224. Brandejsky V, Kreis R, Boesch C. Restricted or severely hindered diffusion in intramyocellular lipids in human skeletal muscle shown by in vivo proton MR spectroscopy. Magn. Reson. Med. 2012; 67: 310-316.
225. Steidle G, Eibofner F, Schick F. Quantitative diffusion imaging of adipose tissue in the human lower leg at 1.5T. Magn. Reson. Med. 2011; 65: 1118-1124.
226. 13C MRS studies of neuroenergetics and neurotransmitter cycling in humans. NMR Biomed. 2011; 24: 943-957.
227. Sbarbati A, Cavallini I, Marzola P, Nicolato E, Osculati F. Contrast-enhanced MRI of brown adipose tissue after pharmacological stimulation. Magn. Reson. Med. 2006; 55: 715-718.
228. Khanna A, Branca RT. Detecting brown adipose tissue activity with BOLD MRI in mice. Magn. Reson. Med. 2012; 68: 1285-1290.
229. Soher BJ, Wyatt C, Reeder SB, MacFall JR. Noninvasive temperature mapping with MRI using chemical shift water-fat separation. Magn. Reson. Med. 2010; 63: 1238-1246.
230. 13C imaging. Int. J. Obes. (Lond) 2013; DOI: 10.1038/ijo.2013.58.
231. 13C]-pyruvate metabolism in brown fat. Proceedings of the 21st Annual Meeting ISMRM, Salt Lake City, Utah, USA, 2013; 3912.
232. Branca RT, White C, Zhang L. Detection of brown fat mass and activity by hyperpolarized xenon MR. Proceedings of the 21st Annual Meeting ISMRM, Salt Lake City, Utah, USA, 2013; 404.
233. Branca RT, Zhang L, White C, He T. Detection of brown fat thermogenesis by hyperpolarized Xenon gas MR. Proceedings of the 21st Annual Meeting ISMRM, Salt Lake City, Utah, USA, 2013; 814.
234. Waldén TB, Hansen IR, Timmons JA, Cannon B, Nedergaard J. Recruited vs. nonrecruited molecular signatures of brown, " brite, " and white adipose tissues. Am. J. Physiol. Endocrinol. Metab. 2012; 302: E19-E31.
235. Cypess AM, White AP, Vernochet C, Schultz TJ, Xue R, Sass CA, Huang TL, Roberts-Toler C, Weiner LS, Sze C, Chacko AT, Deschamps LN, Herder LM, Truchan N, Glasgow AL, Holman AR, Gavrila A, Hasselgren PO, Mori MA, Molla M, Tseng YH. Anatomical localization, gene expression profiling and functional characterization of adult human neck brown fat. Nat. Med. 2013; 19: 635-639.
236. Kelly DP. Irisin, light my fire. Science 2012; 336: 42-43.
237. Nakamura K, Morrison SF. Central efferent pathways mediating skin cooling-evoked sympathetic thermogenesis in brown adipose tissue. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2007; 292: R127-R136.
238. Endo T, Kobayashi T. Thyroid-stimulating hormone receptor in brown adipose tissue is involved in the regulation of thermogenesis. Am. J. Physiol. Endocrinol. Metab. 2008; 295: E514-E518.
239. Ichimiya H, Arakawa S, Sato T, Shimada T, Chiba M, Soma Y, Mizoguchi M, Tomonari K, Iwasaka H, Hatano Y, Okamoto O, Fujiwara S. Involvement of brown adipose tissue in subcutaneous fat necrosis of the newborn. Dermatology 2011; 223: 207-210.
240. van der Veen DR, Shao J, Chapman S, Leevy WM, Duffield GE. A diurnal rhythm in glucose uptake in brown adipose tissue revealed by in vivo PET-FDG imaging. Obesity (Silver Spring) 2012; 20: 1527-1529.